Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Luke Evnin, a director at Werewolf Therapeutics, Inc. (NASDAQ: HOWL), executed a sale of 157,084 shares of the company's common stock on June 29, 2026. The transaction, valued at $47,125, was carried out through a Rule 10b5-1 trading plan established on March 26, 2026. The shares were sold at a weighted average price of $0.30 per share, with indivi…
Box Inc. (NYSE:BOX) Chief Operating Officer Olivia Nottebohm executed a sale of 5,834 Class A common shares on June 25, 2026, realizing $145,674. The transaction, governed by a Rule 10b5-1 plan established in July 2025, stands in contrast to recent positive fundamental developments, including first-quarter fiscal 2027 earnings that beat consensus a…
Michael George Rosenbaum, Chief Executive Officer of Guidewire Software, Inc. (NASDAQ:GWRE), executed a stock sale on June 29, 2026, as documented in a recent regulatory filing. The transaction involved the liquidation of 1,200 shares at $124.29 per share, totaling $149,148. This sale was facilitated through an automated 10b5-1 trading plan establi…
Northwest Natural Holding Co (NASDAQ: NWN) director David Anderson has completed a stock sale as part of a pre-arranged trading plan established before his retirement from the chief executive role. The transaction occurs against a backdrop of recent quarterly earnings results that presented a mixed picture for the utility company, alongside diverge…
Jeffrey E. Eberwein, Chief Executive Officer and Director of Star Equity Holdings, Inc. (NASDAQ: STRR), has executed two separate transactions to acquire 10,000 shares of the company's common stock, totaling $110,100. The purchases occurred on June 25 and June 29, 2026, at a consistent price of $11.01 per share. Following these acquisitions, Eberwe…
Bakkt Holdings Inc. (NASDAQ:BKKT) Chief Accounting Officer Joseph Sean-Walsh Henderson executed a stock sale on June 25, 2026, to settle tax liabilities stemming from restricted stock unit vesting. This transaction occurs against a backdrop of significant corporate restructuring, including the divestiture of the company's loyalty business and a str…
Marc D’Annunzio, serving as General Counsel and Secretary for Bakkt, Inc. (NASDAQ:BKKT), executed a series of share sales totaling 2,919 shares across June 25 and June 26, 2026. The transactions resulted in a total divestment value of $22,849, with share prices fluctuating between $7.71 and $7.93. This activity occurs against a backdrop of signific…
Nicholas Baes, the Chief Operating Officer of Bakkt, Inc., executed a sale of 1,562 Class A Common Stock shares on June 25, 2026, netting $12,386. This transaction was specifically structured to satisfy tax liabilities arising from the vesting of restricted stock units. Following the sale, Baes retains a direct holding of 105,375 shares, with 48,60…
Matthew J. Cox, who serves as both Chairman and Chief Executive Officer of Matson, Inc. (NYSE: MATX), has executed a significant sale of company equity. The transactions involved the disposal of 10,000 shares of common stock on June 29, 2026, resulting in total proceeds of $1,929,124. These sales were conducted at varying price points between $191.…
Karen Alexander, Chief Financial Officer of Bakkt, Inc., executed a sale of 1,907 shares of Class A Common Stock on June 25, 2026, generating $15,122 to cover tax obligations linked to restricted stock unit vesting. Post-transaction, her direct holdings stand at 54,199 shares, including 14,576 subject to vesting schedules. This transaction occurs a…
Lee Sung, Cytokinetics CFO, sold 38,730 shares at $82.30 each on June 24, 2026, after exercising options acquired between $44.36 and $48.51. The transaction occurs as the stock trades near its 52-week high of $87.35, reflecting a 163% annual gain. Analysts have upgraded the stock citing Myqorzo launch momentum, though the company remains unprofitab…
Snowflake Inc. board member Frank Slootman completed a transaction involving the sale of 100 shares on June 26, 2026, generating proceeds of $25,000. The transaction was structured under a 10b5-1 trading plan established in September 2025, following the exercise of fully vested stock options. This activity occurs as Snowflake trades near $252, with…
James Kihara, Principal Accounting Officer at ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD), executed a sale of 11,421 shares on June 26, 2026, totaling approximately $297,912. The transaction, conducted under a pre-established Rule 10b5-1 trading plan adopted in December 2025, leaves Kihara with a direct holding of 13,088 shares. This insider activity …
HRT Financial LP, a significant ten percent shareholder in GD Culture Group Ltd (NASDAQ: GDC), reported substantial trading activity in the company’s common stock, acquiring and disposing of large share volumes in late June 2026. The transactions coincide with GD Culture Group’s ongoing corporate restructuring efforts, including a reverse stock spl…
AtaiBeckley Inc. (NASDAQ: ATAI) reported a significant insider transaction as Chief Operating Officer Gerd Kochendoerfer sold 50,000 shares for $250,000 on June 26, 2026. The sale followed the exercise of stock options acquired at a lower cost, executed under a Rule 10b5-1 trading plan. This financial movement occurs against a backdrop of strong re…
Craig Kevin James, Chief Medical Officer at AtaiBeckley Inc. (NASDAQ: ATAI), executed a series of transactions on June 25, 2026, involving the sale of company stock and the exercise of stock options. The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. These transactions occur against a backdrop of signif…
Ian Sparling, the chief executive officer of WidePoint Corp and an officer at Soft-Ex, liquidated a significant portion of his equity holdings in WidePoint on June 26, 2026. The executive's transactions, totaling approximately $2.59 million, occurred against a backdrop of substantial stock appreciation and recent financial disclosures that highligh…
Sezzle Inc. CFO Brading Dickson executed a series of stock sales totaling approximately $1.68 million in late June, with transactions processed under a pre-arranged Rule 10b5-1 trading plan. The divestment occurs against a backdrop of divergent analyst ratings, with Oppenheimer downgrading the stock due to valuation concerns following a significant…
Aaron Tachibana, serving as both Chief Financial Officer and Chief Operating Officer at Personalis, Inc. (NASDAQ: PSNL), executed a series of stock transactions on June 29, 2026. These moves, conducted under a pre-existing Rule 10b5-1 trading plan, involved both the sale of common shares and the acquisition of new shares through option exercises. C…
Jason Holloway, Executive Vice President and Chief Sales and Market Officer at WidePoint Corp (NASDAQ:WYY), executed a series of stock sales totaling 181,740 shares on June 26, 2026. The transactions generated approximately $3.14 million, with share prices ranging from $16.20 to $19.52. This divestment occurs against a backdrop of significant stock…
Blackstone Mortgage Trust Inc. (NYSE:BXMT) President Fernando Austin Pena completed a share sale on June 25, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction, totaling $41,917, was initiated to satisfy tax withholding obligations tied to the vesting of restricted stock awards. This activity occurs as the company navigates rec…
J.M. Smucker Co. Chief Legal Officer Jeannette L. Knudsen executed a significant share disposal on June 26, 2026, according to regulatory filings. The transaction coincides with a period of heightened analyst confidence and positive earnings momentum for the consumer staples manufacturer. Knudsen's sale reduces her direct equity stake, though she r…
Brian Guan-Chyun Liu, a director at CG Oncology, Inc., has significantly increased his stake in the company through a substantial recent purchase. This transaction follows positive clinical trial results for the company's lead asset and has been met with upgraded analyst sentiment, highlighting growing institutional interest in the oncology sector.
Lee Sung, serving as Executive Vice President and Chief Financial Officer at CYTOKINETICS INC (NASDAQ:CYTK), executed a transaction involving the sale of company common stock on June 29, 2026. The disposition involved 3,134 shares, generating total proceeds of $266,390. These shares were acquired on the same calendar day through the exercise of var…
Block, Inc. director Anthony Mathew Eisen executed three separate sales of Class A Common Stock last week, totaling $1,376,580. The transactions, facilitated through a pre-arranged Rule 10b5-1 trading plan, involved the disposal of 18,000 shares across June 25, 26, and 29, 2026. Despite the insider activity, Block's stock has demonstrated significa…
